Joshua B. Cohen, Co-Chief Executive Officer at Amylyx Pharmaceuticals, Inc. (AMLX), sold 29,282 shares at $14.48 ($424K) on 2026-03-02, disclosed to the SEC on 2026-03-04.
Seasonal sale ($424k) by Co-Chief Executive Officer — this insider has traded AMLX in March in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| AMLX | SELL | 2026-01-20 | $1.9M | — | Filing → |
| AMLX | SELL | 2026-01-08 | $86K | — | Filing → |
| AMLX | SELL | 2025-10-02 | $856K | — | Filing → |